SP110 and osteosarcoma: For instance, the expression of histocompatibility proteins and other immune-related factors has been associated with osteosarcoma development (Zhao et al., 2015), suggesting that SP110 may play a role in modulating the immune environment surrounding the tumor, potentially affecting its progression through immune evasion or modulation of inflammatory responses.